Overview
Sage Infusion provides infusion therapy services in the Central and Southwest Florida region, offering full-service IV treatments for autoimmune disorders and chronic illnesses such as MS, RA, Crohn’s disease, ulcerative colitis, TED, Alzheimer’s, osteoporosis, and lupus. Treatments are administered in a clinical setting under professional supervision using scheduled infusion regimens, with the center open extended hours including weekends. It accepts Medicare and all major commercial health insurance to simplify access. The company differentiates itself by prioritizing the patient experience and accessibility—extended hours, weekend availability, and broad insurance acceptance—so people can receive infusion care more conveniently. The goal is to deliver reliable, accessible infusion therapy for patients with complex health needs within its Florida service area.
Work here?Claim your company
Simplify's Take
What believers are saying
- Sage opened its 15th clinic in Trinity on August 12, 2026, proving execution.
- Management targeted ten new Florida clinics in 2026, creating dense local referral coverage.
- The company raised $11.8 million in March 2026 and markets an Amgen-supported relationship.
What critics are saying
- Sage excludes Medicaid, blocking a large Florida patient pool and limiting payer diversification.
- The March 2026 $24.7 million offering still requires follow-on capital for 2026 expansion.
- Hospital systems and national infusion chains can compress reimbursement, and expansion failure kills the network.
What makes Sage Infusion unique
- Sage Infusion runs 15 Florida clinics by August 2026, all community-based infusion centers.
- It treats complex non-oncology conditions, from Crohn's to MS, with nurse practitioner-led care.
- It coordinates referrals, insurance, and follow-up in-house, reducing friction versus hospital infusion departments.
Help us improve and share your feedback! Did you find this helpful?